Transforming Growth Factors β1 and β2 in the Cerebrospinal Fluid of Chronic Schizophrenic Patients

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Neuropsychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0893-133X(96)00143-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neural functions of the transforming growth factors β

  1995cited by this paper
• Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease

  1995cited by this paper
• Transforming growth factor-beta 1 regulates axon/Schwann cell interactions

  1995cited by this paper
• Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.

  1995cited by this paper
• Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia.

  1995cited by this paper
• Induction of NCAM expression in mouse olfactory keratin-positive basal cells in vitro.

  1995cited by this paper
• TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

  1995cited by this paper
• Elevation of Transforming Growth Factor‐&bgr;1 Level in Cerebrospinal Fluid of Patients With Communicating Hydrocephalus After Subarachnoid Hemorrhage

  1994cited by this paper
• Plasma and Cerebrospinal Fluid lnterleukin-1 β and lnterleukin-6 in Hospitalized Schizophrenic Patients

  1994cited by this paper
• Transient Production of TGF‐β2 by Postnatal Cerebellar Neurons and its Effect on Neuroblast Proliferation

  1994cited by this paper
• Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity.

  1994cited by this paper
• Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.

  1993cited by this paper
• Peptide growth factor control of olfactory neurogenesis and neuron survival in vitro: Roles of EGF and TGF-βs

  1993cited by this paper
• Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects

  1993cited by this paper
• Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS.

  1993cited by this paper
• Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation

  1992cited by this paper
• Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia.

  1992cited by this paper
• Glioblastoma, transforming growth factor-beta, and Candida meningitis: a potential link.

  1992cited by this paper
• Astrocyte-derived TGF-beta 2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes

  1991cited by this paper

• SCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity

  2021cites this paper
• Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies.

  2019cites this paper
• Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis

  2018cites this paper
• Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.

  2018cites this paper
• Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression

  2018cites this paper
• Possible Role of TGF – B Pathways in Schizophrenia / Moguća Uloga TTGF - B Signalnih Puteva U Shizofreniji

  2016cites this paper
• Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases.

  2014cites this paper
• Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response.

  2013cites this paper
• Increased interleukin-6 level in Taiwanese schizophrenic patients.

  2011cites this paper
• Schizophrenia: A Pathogenetic Autoimmune Disease Caused by Viruses and Pathogens and Dependent on Genes

  2011cites this paper
• Anti-inflammatory signaling in schizophrenia.

  2011cites this paper
• Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond.

  2011cites this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cites this paper
• Metaanálisis de los estudios publicados sobre alteraciones de los valores de las citocinas en la esquizofrenia: efectos del estado clínico y de los antipsicóticos

  2011cites this paper
• Transforming growth factor beta concentrations and interferon gamma responses in cerebrospinal fluid of horses with equine protozoal myeloencephalitis.

  2010cites this paper
• Effect of TGF-β1 polymorphism on the susceptibility to schizophrenia and treatment response to atypical antipsychotic agent

  2010cites this paper
• Cytokine imbalance in the pathophysiology of major depressive disorder.

  2007cites this paper
• Novel role of TGF‐β in differential astrocyte‐TIMP‐1 regulation: Implications for HIV‐1‐dementia and neuroinflammation

  2006cites this paper
• Cytokine networks in patients with schizophrenia and their possible role in its pathophysiology

  2004cites this paper
• Cytokines and schizophrenia

  2003cites this paper
• T-helper-1 and T-helper-2 responses in psychiatric disorders.

  2001cites this paper
• Characterization of a model of hydrocephalus in transgenic mice

  1999cites this paper
• Characterization of a model of hydrocephalus in transgenic mice.

  1999cites this paper
• Abnormal expression of cell recognition molecules in schizophrenia.

  1998cites this paper